LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
XMAX
XMAX, Inc.
There isn't enough reported data to score XMAX yet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
XMAX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Unavailable | |
| Strong |
XMAX's revenue and balance sheet are currently healthy, and its profitability is stable. There isn't enough data to rate its cash flow.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
XMAX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 16x | $6.56 | — |
| Cheap | 17x | $6.78 | +3.4% |
| Fair | 21x | $8.62 | +31% |
| Expensive | 21x | $8.73 | +33% |
Historical ranges are pointers, not guarantees.
XMAX's PE is 16x, but its earnings don't support one, so it isn't a reliable read right now.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
XMAX Forward outlook
There aren't enough analyst estimates for XMAX to show an outlook.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
XMAX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.41 | +$1.49 |
| Q1 2026 | -$0.14 | +$1.14 |
| Q4 2025 | -$0.17 | +$1.73 |
| Q3 2025 | -$0.42 | +$4.08 |
| Q2 2025 | -$1.08 | +$3.53 |
| Q1 2025 | -$1.28 | +$3.48 |
| Q4 2024 | -$1.90 | +$3.06 |
| Q3 2024 | -$4.50 | +$3.90 |
XMAX has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over XMAX on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
XMAX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $2.7M | +7.1% |
| Q1 2026 | $1.8M | -32% |
| Q4 2025 | $1.8M | -12% |
| Q3 2025 | $9.8M | +273% |
| Q2 2025 | $2.6M | -4.9% |
| Q1 2025 | $2.6M | +11% |
| Q4 2024 | $2M | -12% |
| Q3 2024 | $2.6M | +5.6% |
XMAX's revenue is growing: $3M last quarter, up 7.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -44% | -37 points |
| Q1 2026 | -30% | -23 points |
| Q4 2025 | -59% | -11 points |
| Q3 2025 | -5% | +87 points |
| Q2 2025 | -7.7% | +11 points |
| Q1 2025 | -7.3% | +55 points |
| Q4 2024 | -48% | +119 points |
| Q3 2024 | -92% | -50 points |
XMAX has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
XMAX has the stronger cash trend. Its trailing FCF is up 57% versus its history, compared with LCID at down 75%.
XMAX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$641.7K | -$319.1K |
| Q3 2025 | -$1.9M | -$1.5M |
| Q2 2025 | $92.5K | +$561.2K |
| Q1 2025 | -$322.6K | -$100.9K |
| Q4 2024 | -$263.4K | +$2.8M |
| Q1 2024 | -$221.7K | +$510.7K |
| Q4 2023 | -$3.1M | -$1.2M |
| Q1 2023 | -$732.4K | +$124.2K |
XMAX has burned cash in almost every quarter: −$3M over the past year, against −$1M the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has the edge over XMAX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
XMAX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +36% | +16.2M shares |
| 1 year | +524% | +51.2M shares |
| 3 years | +4302% | +59.6M shares |
| 5 years | +5213% | +59.9M shares |
| Available history | +5210% | +59.9M shares |
XMAX has 61M diluted shares, up 524% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q3 2019 | $405,421 |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
XMAX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2019 | -1.0x | Net Cash |
| Q2 2019 | -4.5x | Net Cash |
XMAX has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
XMAX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.5 | Neutral |
| Stochastic | 30.6 | Neutral |
XMAX's weekly RSI is 41 (neutral) and its Stochastic is 31 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
XMAX PE vs Consumer Cyclical Sector
| Metric | XMAX | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 11% below |
XMAX is trading at 16x earnings, a 11% discount to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
XMAX has stronger trend alignment. LCID is above 0 of 5 weekly averages versus XMAX above 1 of 4.
XMAX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.64 | 14% below |
| 20 week MA | $8.29 | 21% below |
| 50 week MA | $7.48 | 12% below |
| 100 week MA | $4.85 | 35% above |
XMAX has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 35% above its 100-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
XMAX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $3.77 | $3.77 | 0% |
| 2024 | $3.77 | $0.53 | -86% |
| 2025 | $0.53 | $6.00 | +1032% |
| 2026 YTD | $6.00 | $6.56 | +9.3% |
XMAX has the edge over LCID on returns for 2026, with the stronger performance.